Keywords: rx, expenditures, still, trending, up, forecast, slow
US Rx expenditures still trending up, but are forecast to slow this year
Article | 17 June 2002
Rapid upward prescription drug spending growth in the USA continued infirst-quarter 2002, but at 19.3% compared to 19.8% in first-quarter 2001, estimates Express Scripts' ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
